Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Jonesboro, AR
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Jacksonville, FL
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Macon, GA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Marietta, GA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Valdosta, GA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Valdosta, GA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Post Falls, ID
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Post Falls, ID
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Westwood, KA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Westwood, KA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Wichita, KA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Baton Rouge, LA
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Billings, MT
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Columbus, OH
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Charleston, SC
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Germantown, TN
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Memphis, TN
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Morgantown, WV
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
IPI-504 in NSCLC Patients With ALK Translocations
A Phase II Study of IPI-204, A Novel Hsp90 Inhibitor in NSCLC Patients With ALK Translocations
Status: Enrolling
Updated:  10/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
IPI-504 in NSCLC Patients With ALK Translocations
A Phase II Study of IPI-204, A Novel Hsp90 Inhibitor in NSCLC Patients With ALK Translocations
Status: Enrolling
Updated: 10/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
IPI-504 in NSCLC Patients With ALK Translocations
A Phase II Study of IPI-204, A Novel Hsp90 Inhibitor in NSCLC Patients With ALK Translocations
Status: Enrolling
Updated:  10/28/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
IPI-504 in NSCLC Patients With ALK Translocations
A Phase II Study of IPI-204, A Novel Hsp90 Inhibitor in NSCLC Patients With ALK Translocations
Status: Enrolling
Updated: 10/28/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Athens, GA
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Athens, GA
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Scarborough, ME
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Torrington, CT
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Torrington, CT
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Marietta, GA
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Cherry Hill, NJ
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Albuquerque, NM
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Charleston, SC
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Memphis, TN
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated:  10/28/2017
mi
from
Seoul,
A Study for Participants With Small-Cell Lung Cancer
A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
Status: Enrolling
Updated: 10/28/2017
mi
from
Seoul,
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Bethesda, MD
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Fort Myers, FL
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Pensacola, FL
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Pensacola, FL
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Gainesville, GA
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Cincinnati, OH
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Toledo, OH
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Columbia, SC
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Spartanburg, SC
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Chattanooga, TN
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Nashville, TN
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Fort Worth, TX
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated:  10/28/2017
Clinical Research Facility
mi
from
Richmond, VA
A Study of LY2523355 in Participants With Breast Cancer
A Randomized Phase 2 Study of LY2523355 Versus Ixabepilone in Patients With Metastatic or Locally Recurrent Breast Cancer Who Have Received Prior Taxane Therapy
Status: Enrolling
Updated: 10/28/2017
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Phase II Study of Spinal Radiosurgery
A Phase II Study of Spinal Radiosurgery
Status: Enrolling
Updated:  10/30/2017
University of Alabama at Birmingham/The Kirklin Clinic at Acton Road
mi
from
Birmingham, AL
A Phase II Study of Spinal Radiosurgery
A Phase II Study of Spinal Radiosurgery
Status: Enrolling
Updated: 10/30/2017
University of Alabama at Birmingham/The Kirklin Clinic at Acton Road
mi
from
Birmingham, AL
Click here to add this to my saved trials
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia
Status: Enrolling
Updated:  10/30/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia
Status: Enrolling
Updated: 10/30/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia
Status: Enrolling
Updated:  10/30/2017
Albuquerque Veterans Administration Medical Center
mi
from
Albuquerque, NM
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia
Status: Enrolling
Updated: 10/30/2017
Albuquerque Veterans Administration Medical Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia
Status: Enrolling
Updated:  10/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia
Status: Enrolling
Updated: 10/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia
Status: Enrolling
Updated:  10/30/2017
BCCA-Vancouver Cancer Centre
mi
from
Vancouver,
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia
Status: Enrolling
Updated: 10/30/2017
BCCA-Vancouver Cancer Centre
mi
from
Vancouver,
Click here to add this to my saved trials
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study to Evaluate the Feasibility of a Breast Cancer Rehabilitation Program in Survivors of Breast Cancer
Status: Enrolling
Updated:  10/30/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study to Evaluate the Feasibility of a Breast Cancer Rehabilitation Program in Survivors of Breast Cancer
Status: Enrolling
Updated: 10/30/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Phase II Trial of Pre-operative Bevacizumab and FOLFOX Chemotherapy in Locally Advanced Esophageal Cancer
Status: Enrolling
Updated:  10/30/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Phase II Trial of Pre-operative Bevacizumab and FOLFOX Chemotherapy in Locally Advanced Esophageal Cancer
Status: Enrolling
Updated: 10/30/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Phase II Trial of Pre-operative Bevacizumab and FOLFOX Chemotherapy in Locally Advanced Esophageal Cancer
Status: Enrolling
Updated:  10/30/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Phase II Trial of Pre-operative Bevacizumab and FOLFOX Chemotherapy in Locally Advanced Esophageal Cancer
Status: Enrolling
Updated: 10/30/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Phase II Trial of Pre-operative Bevacizumab and FOLFOX Chemotherapy in Locally Advanced Esophageal Cancer
Status: Enrolling
Updated:  10/30/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Phase II Trial of Pre-operative Bevacizumab and FOLFOX Chemotherapy in Locally Advanced Esophageal Cancer
Status: Enrolling
Updated: 10/30/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
Pioglitazone as a Candidate Chemoprevention Agent for Lung Cancer: A Pilot Trial Using a Pre-surgical Model in Early Stage NSCLC
Status: Enrolling
Updated:  10/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
Pioglitazone as a Candidate Chemoprevention Agent for Lung Cancer: A Pilot Trial Using a Pre-surgical Model in Early Stage NSCLC
Status: Enrolling
Updated: 10/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials